{"cik":1737523,"taxonomy":"us-gaap","tag":"CurrentIncomeTaxExpenseBenefit","label":"Current Income Tax Expense (Benefit)","description":"Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.","entityName":"BioNexus Gene Lab Corp.","units":{"USD":[{"start":"2024-01-01","end":"2024-12-31","val":-15799,"accn":"0001477932-26-002218","fy":2025,"fp":"FY","form":"10-K","filed":"2026-04-14","frame":"CY2024"},{"start":"2025-01-01","end":"2025-03-31","val":0,"accn":"0001477932-26-003242","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-15","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-06-30","val":0,"accn":"0001477932-26-005093","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-14"},{"start":"2025-01-01","end":"2025-12-31","val":0,"accn":"0001477932-26-002218","fy":2025,"fp":"FY","form":"10-K","filed":"2026-04-14","frame":"CY2025"},{"start":"2026-01-01","end":"2026-03-31","val":0,"accn":"0001477932-26-003242","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-15","frame":"CY2026Q1"},{"start":"2026-01-01","end":"2026-06-30","val":0,"accn":"0001477932-26-005093","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-14"}]}}